Key result
Thrombolytic therapy for the resolution of arterial and venous thrombi is discussed in the context of recent clinical trials.
Answers are grounded in this paper and cite their sources.
Supports fibrinolysis enhancement for thrombus resolution; leaves open clinical efficacy in arterial and venous thrombosis.
ALTHOUGH many details of the process of thrombogenesis are unclear, it is generally thought that it involves both platelet activity (adhesion and aggregation) and fibrin formation.1 , 2 Both processes appear to be active in arterial and venous thrombogenesis, although their relative importance is not certain. In any event, physiologic fibrinolysis is theoretically important in the resolution of both arterial and venous thrombi, and agents which enhance this process may function as thrombolytic agents. Experimental studies dealing with this hypothesis have been extensive and are generally reviewed elsewhere.3 , 4 More recently, a number of clinical trials have been conducted to evaluate thrombolytic therapy. . . .
No takes yet. Share an insight, caveat, or question.
Fratantoni et al. (1975) conducted a review in Arterial and venous thrombosis. Thrombolytic therapy was evaluated. Thrombolytic therapy for the resolution of arterial and venous thrombi is discussed in the context of recent clinical trials.
Synapse has enriched 10 related papers. Consider them for comparative context: